Skip to main content
Premium Trial:

Request an Annual Quote

CuraGen Has Two Patents For Gene Expression Tool

Premium

NEW HAVEN, Conn.--CuraGen said it has been granted a second US patent covering its open architecture technology for discovering genes, measuring gene expression, and enabling pharmacogenomics research. Specifically, the company said the new patent covers the apparatus and computer systems utilized in its GeneCalling system, which was discussed in a peer-reviewed paper published in the August, 1999, issue of Nature Biotechnology. GeneCalling is a high-throughput method for analyzing differences in gene expression and gene sequence and comparing results to public and proprietary sequence databases.

Filed under

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.